KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

(HealthDay News) — Incidence and mortality from renal cancer (RC) may double by 2050, according to a study published in the October issue of European Urology.

Urological cancers, including bladder cancer, renal cell carcinoma, prostate cancer, and urothelial carcinoma, represent a ...

Specific to patients with muscle invasive bladder cancer, improvement in disease free survival was also observed with nivolumab versus placebo in all randomized patients (HR 0.66, 95% CI 0.53-0.81) ...